🧬🌍 Today marks Rare Disease Day – an annual event that aims to raise awareness and generate change for the 300 million people worldwide living with a rare disease, their families, and carers.
To celebrate #RareDiseaseDay, we are back with another podcast episode of Conversations in Drug Development, this time discussing the unique challenges of rare disease drug development.
Dr Eric Hardter, Associate Director of Regulatory Affairs at Boyds, joins our host Harriet Edwards, to discuss regulatory considerations, overcoming clinical trial hurdles and FDA initiatives for rare disease drug development.
Tune in by searching for “Conversations in Drug Development” on your preferred streaming platform or visit Podcast | Conversations in Drug Development | Boyds (boydconsultants.com).
New Podcast Episode of Conversations in Drug Development
Feb 29, 2024
The regulatory challenges of rare disease drug development
Posted by Boyds